V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006349 | 200011633 | 1.77 | 105.3 | Palliative (P) | 2019-03-30 | 2019-04-11 | DABRAFENIB | 02 | N | DABRAFENIB | 100173131 |
| 200006350 | 200011634 | 1.73 | 55.8 | Palliative (P) | 2019-09-15 | 2019-09-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100643422 |
| 200006357 | 200011641 | null | null | null | null | 2018-08-07 | null | null | null | CARBOPLATIN + DOCETAXEL | 100242050 |
| 200006359 | 200011643 | null | 95.5 | Palliative (P) | 2021-02-17 | 2021-03-10 | DABRAFENIB | 02 | null | DABRAFENIB | 100832640 |
| 200006360 | 200011644 | 1.62 | 67 | Palliative (P) | 2016-03-21 | 2016-03-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101602508 |
| 200006361 | 200011645 | 1.75 | 81.65 | Palliative (P) | 2018-08-05 | 2018-08-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100762396 |
| 200006362 | 200011646 | 1.81 | 126 | null | 2022-03-11 | 2022-03-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100224201 |
| 200006365 | 200011649 | 1.64 | 88.85 | null | 2019-04-26 | 2019-05-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101184290 |
| 200006368 | 200011652 | 1.7 | 74 | null | 2019-06-05 | 2019-06-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100103099 |
| 200006370 | 200011654 | 1.81 | 87.8 | null | 2018-11-23 | 2018-11-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100220315 |
| 200006371 | 200011655 | 1.66 | 161.7 | Palliative (P) | 2020-07-16 | 2020-07-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100829890 |
| 200006372 | 200011656 | 1.77 | 58.9 | Palliative (P) | 2021-01-26 | 2021-08-30 | COLUMBUS trial | 02 | null | IPILIMUMAB | 100193085 |
| 200006374 | 200011658 | 1.73 | 75 | Palliative (P) | null | 2019-11-02 | Dacarbazine | 02 | null | IPILIMUMAB | 100176529 |
| 200006376 | 200011660 | 1.73 | 62 | Palliative (P) | 2017-08-31 | 2017-09-01 | null | N | null | DABRAFENIB | 101081559 |
| 200006378 | 200011662 | 1.8 | 87 | null | 2018-04-27 | 2018-04-29 | null | 02 | null | DABRAFENIB | 101820772 |
| 200006379 | 200011663 | null | 76 | Palliative (P) | 2017-09-15 | 2017-09-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100068281 |
| 200006382 | 200011666 | null | null | Adjuvant (A) | 2016-10-10 | 2016-10-24 | DABRAFENIB | 02 | N | DABRAFENIB | 101169165 |
| 200006387 | 200011670 | 0 | 0 | Palliative (P) | 2018-11-03 | 2018-11-25 | Dacarbazine | N | N | IPILIMUMAB + NIVOLUMAB | 101393261 |
| 200006388 | 200011671 | 1.66 | 80.4 | Palliative (P) | 2020-06-20 | 2020-06-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100790630 |
| 200006390 | 200011673 | 1.67 | 70 | Palliative (P) | 2018-01-13 | 2018-01-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101339222 |
| 200006391 | 200011674 | null | 75 | Palliative (P) | 2019-02-25 | 2019-03-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100146517 |
| 200006393 | 200011676 | null | 60 | Palliative (P) | null | 2017-02-25 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101027391 |
| 200006394 | 200011677 | 1.72 | 111.85 | Adjuvant (A) | null | 2019-08-19 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100408647 |
| 200006395 | 200011678 | null | null | null | null | 2018-12-15 | null | null | null | TRIAL | 100805505 |
| 200006396 | 200011679 | 0 | 0 | Palliative (P) | 2016-04-06 | 2016-04-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100394459 |
| 200006397 | 200011680 | 1.81 | 90 | Palliative (P) | 2017-12-24 | 2017-12-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101059769 |
| 200006398 | 200011681 | 1.77 | 54.8 | Palliative (P) | 2020-08-27 | 2020-09-24 | DABRAFENIB | 02 | N | IPILIMUMAB | 101150148 |
| 200006399 | 200011682 | 1.79 | 168.8 | Palliative (P) | 2019-05-13 | 2019-05-15 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100363171 |
| 200006404 | 200011687 | null | 64.9 | Palliative (P) | 2018-06-13 | 2018-06-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100725494 |
| 200006405 | 200011688 | 1.8 | 111 | Palliative (P) | 2017-08-01 | 2017-10-04 | FEC + TRASTUZUMAB | 02 | null | TRIAL UNSPECIFIED | 100455515 |
| 200006407 | 200011690 | 1.61 | 78.4 | Palliative (P) | 2016-07-28 | 2016-09-09 | TALIMOGENE LAHERPAREPVEC | 02 | null | DABRAFENIB | 100960974 |
| 200006408 | 200011691 | 1.51 | 89 | Palliative (P) | 2020-03-08 | 2020-03-08 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100729550 |
| 200006409 | 200011692 | 1.64 | 60 | Palliative (P) | 2018-07-19 | 2018-07-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100908042 |
| 200006410 | 200011693 | 1.74 | 82.4 | Palliative (P) | 2017-01-26 | 2018-05-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101617973 |
| 200006411 | 200011694 | 1.7 | 87 | Palliative (P) | 2017-03-07 | 2017-03-11 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100914365 |
| 200006412 | 200011695 | 1.84 | 79.1 | Palliative (P) | 2020-03-23 | 2020-03-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100932755 |
| 200006415 | 200011697 | null | 87.6 | Palliative (P) | null | 2018-12-05 | null | null | N | BINIMETINIB + ENCORAFENIB | 100075272 |
| 200006418 | 200011699 | 1.66 | null | Palliative (P) | 2016-07-03 | 2016-07-06 | INTERIM Trial | 02 | null | IPILIMUMAB + NIVOLUMAB | 101194611 |
| 200006420 | 200011701 | 1.68 | 58 | Curative (C) | 2015-12-13 | 2017-02-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101851221 |
| 200006421 | 200011702 | 1.52 | 70.4 | Palliative (P) | 2018-07-10 | 2018-07-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101834781 |
| 200006422 | 200011703 | 1.81 | 107 | Adjuvant (A) | 2020-07-15 | 2020-07-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100877777 |
| 200006426 | 200011707 | 1.79 | 75 | Palliative (P) | null | 2019-07-26 | null | null | N | BINIMETINIB + ENCORAFENIB | 101400664 |
| 200006427 | 200011708 | 1.88 | 47 | Palliative (P) | 2016-06-30 | 2017-06-09 | Ipilimumab | null | null | IPILIMUMAB | 100135227 |
| 200006429 | 200011709 | 1.47 | 75.2 | Palliative (P) | 2020-05-06 | 2020-05-06 | Ipilimumab | N | null | DABRAFENIB | 101807101 |
| 200006431 | 200011711 | 1.6 | 81.1 | Adjuvant (A) | null | 2019-11-27 | null | 01 | N | TRIAL UNSPECIFIED | 100573544 |
| 200006433 | 200011713 | 1.6 | 81 | Palliative (P) | 2016-07-18 | 2016-07-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100478334 |
| 200006434 | 200011714 | null | 64.5 | Adjuvant (A) | 2016-04-11 | 2016-04-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | TRIAL UNSPECIFIED | 101778917 |
| 200006435 | 200011715 | 0 | 0 | Palliative (P) | 2021-11-14 | 2021-11-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101416584 |
| 200006436 | 200011716 | 1.61 | 103 | Palliative (P) | 2019-07-19 | 2019-08-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100760336 |
| 200006437 | 200011717 | null | null | null | null | 2017-05-04 | null | null | null | BINIMETINIB + ENCORAFENIB | 100301048 |